Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Deshang Pharmaceutical is a Chinese pharmaceutical company headquartered in Dunhua, Jilin Province, specializing in the development and manufacture of Traditional Chinese Medicine (TCM) and chemical drugs. The company leverages the rich natural herbal resources of the Changbai Mountain region to produce a wide range of products, including granules, tablets, and capsules. Its core portfolio focuses on pediatric respiratory health, cardiovascular treatments, and digestive system medications, with flagship products such as Xiaoer Kechuanling Granules and Compound Danshen Tablets. Deshang Pharmaceutical operates multiple GMP-certified production lines and maintains a robust distribution network across China. The company is listed on the National Equities Exchange and Quotations (NEEQ) and continues to invest in the modernization of traditional herbal formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 吉林省德商药业.